2021 KDIGO临床实践指南：慢性肾脏病患者的血压管理

2021-02-23 改善全球肾脏病预后组织 Kidney International (2021) 99, 559–569.

2021年2月，改善全球肾脏病预后组织（KDIGO）发布了2021版慢性肾脏病（CKD）血压管理临床实践指南。该指南是对2012年版指南的更新，包括11项推荐和若干实践要点，主要适用于未接受透析的CK

中文标题：

英文标题：

KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

发布机构：

改善全球肾脏病预后组织

发布日期：

2021-02-23

简要介绍：

2021年2月，改善全球肾脏病预后组织（KDIGO）发布了2021版慢性肾脏病（CKD）血压管理临床实践指南。该指南是对2012年版指南的更新，包括11项推荐和若干实践要点，主要适用于未接受透析的CKD患者。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=273891c0020e27f7, title=2021 KDIGO临床实践指南：慢性肾脏病患者的血压管理, enTitle=KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease, guiderFrom=Kidney International (2021) 99, 559–569., authorId=0, author=, summary=2021年2月，改善全球肾脏病预后组织（KDIGO）发布了2021版慢性肾脏病（CKD）血压管理临床实践指南。该指南是对2012年版指南的更新，包括11项推荐和若干实践要点，主要适用于未接受透析的CK, cover=https://img.medsci.cn/2021325/1616684613324_2020535.jpg, journalId=0, articlesId=null, associationId=108, associationName=改善全球肾脏病预后组织, associationIntro=改善全球肾脏病预后组织(Kidney Disease: ImprovingGlobal Outcomes,KDIGO)是一个国际性的非营利性组织,旨在通过促进和协调世界范围内的大合作,整合已有的相关工作,制定出适用于慢性肾病患者的临床实践指南,并在世界不同地区加以推广,以改善全球肾病患者的预后。, copyright=0, guiderPublishedTime=Tue Feb 23 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年2月，改善全球肾脏病预后组织（KDIGO）发布了2021版慢性肾脏病（CKD）血压管理临床实践指南。该指南是对2012年版指南的更新，包括11项推荐和若干实践要点，主要适用于未接受透析的CKD患者。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=2527, tagName=慢性肾脏病)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2527, guiderKeyword=慢性肾脏病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12604, appHits=691, showAppHits=0, pcHits=1886, showPcHits=11907, likes=6, shares=56, comments=43, approvalStatus=1, publishedTime=Thu Mar 25 23:31:11 CST 2021, publishedTimeString=2021-02-23, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Mar 25 23:03:43 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 07:11:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 KDIGO临床实践指南：慢性肾脏病患者的血压管理.pdf)])

2021 KDIGO临床实践指南：慢性肾脏病患者的血压管理.pdf

下载请点击：

评论区 (32)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1201074, encodeId=29f712010e47e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:12:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199395, encodeId=771911993950c, content=我要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db3a6455137, createdName=ms2000001050457721, createdTime=Fri Mar 04 15:37:39 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187974, encodeId=32fc118e97467, content=英文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Tue Jan 25 11:08:16 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178934, encodeId=4eea11e893435, content=我要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=ms9000002108190477, createdTime=Thu Dec 30 18:15:00 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082152, encodeId=ad201082152d7, content=这是中文版的还是英文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e19b1551932, createdName=hn29585994, createdTime=Mon Dec 20 17:05:21 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
2022-03-09 ms9000001115066421

学习了

64 0
[GetPortalCommentsPageByObjectIdResponse(id=1201074, encodeId=29f712010e47e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:12:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199395, encodeId=771911993950c, content=我要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db3a6455137, createdName=ms2000001050457721, createdTime=Fri Mar 04 15:37:39 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187974, encodeId=32fc118e97467, content=英文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Tue Jan 25 11:08:16 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178934, encodeId=4eea11e893435, content=我要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=ms9000002108190477, createdTime=Thu Dec 30 18:15:00 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082152, encodeId=ad201082152d7, content=这是中文版的还是英文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e19b1551932, createdName=hn29585994, createdTime=Mon Dec 20 17:05:21 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
2022-03-04 ms2000001050457721

我要积分

76 0
[GetPortalCommentsPageByObjectIdResponse(id=1201074, encodeId=29f712010e47e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:12:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199395, encodeId=771911993950c, content=我要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db3a6455137, createdName=ms2000001050457721, createdTime=Fri Mar 04 15:37:39 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187974, encodeId=32fc118e97467, content=英文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Tue Jan 25 11:08:16 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178934, encodeId=4eea11e893435, content=我要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=ms9000002108190477, createdTime=Thu Dec 30 18:15:00 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082152, encodeId=ad201082152d7, content=这是中文版的还是英文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e19b1551932, createdName=hn29585994, createdTime=Mon Dec 20 17:05:21 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
2022-01-25 ms9000001115066421

英文版

74 0
[GetPortalCommentsPageByObjectIdResponse(id=1201074, encodeId=29f712010e47e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:12:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199395, encodeId=771911993950c, content=我要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db3a6455137, createdName=ms2000001050457721, createdTime=Fri Mar 04 15:37:39 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187974, encodeId=32fc118e97467, content=英文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Tue Jan 25 11:08:16 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178934, encodeId=4eea11e893435, content=我要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=ms9000002108190477, createdTime=Thu Dec 30 18:15:00 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082152, encodeId=ad201082152d7, content=这是中文版的还是英文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e19b1551932, createdName=hn29585994, createdTime=Mon Dec 20 17:05:21 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
2021-12-30 ms9000002108190477

我要积分

76 0
[GetPortalCommentsPageByObjectIdResponse(id=1201074, encodeId=29f712010e47e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:12:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199395, encodeId=771911993950c, content=我要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db3a6455137, createdName=ms2000001050457721, createdTime=Fri Mar 04 15:37:39 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187974, encodeId=32fc118e97467, content=英文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Tue Jan 25 11:08:16 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178934, encodeId=4eea11e893435, content=我要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4bc6441444, createdName=ms9000002108190477, createdTime=Thu Dec 30 18:15:00 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082152, encodeId=ad201082152d7, content=这是中文版的还是英文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e19b1551932, createdName=hn29585994, createdTime=Mon Dec 20 17:05:21 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
2021-12-20 hn29585994

这是中文版的还是英文

74 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肾内科指南

2021 KDIGO临床实践指南：慢性肾脏病患者的血压管理

相关指南

拓展阅读

科室

工具

服务